Author: seoworks_web

  • Outsourcing Clinical Trials: Key Considerations for Sponsors

    Outsourcing Clinical Trials: Key Considerations for Sponsors

    Outsourcing is common practice in clinical trials; as the global clinical research market becomes ever more competitive, small to mid-size pharmaceutical and biotech companies must rely on the expertise, services and facilities of specialist clinical research organisations (CROs) and functional service providers (FSPs) to support their clinical development programs. By partnering with outside expertise, smaller…

  • Common challenges in bioanalytical method development

    Common challenges in bioanalytical method development

    The development of bioanalytical methods and subsequent quantification of analytes in a range of biological matrices is fundamental to the drug discovery and development process. Having a reliable and robust methodology, for all target species, including human, plays a key role in understanding how investigational drugs are metabolised following administration.  By accurately evaluating both the…

  • Clinical Considerations for First-in-Human (FIH) and Early Phase Clinical Trials

    Clinical Considerations for First-in-Human (FIH) and Early Phase Clinical Trials

    You are coming close to having completed your nonclinical studies and you are beginning to think about your next steps.  But exactly what are those?  Chances are you are moving into unknown territory with your asset, and you may even have a crucial milestone to consider.  How do you navigate your way through the regulatory…

  • Project Management for Clinical Trials

    Project Management for Clinical Trials

    The world of medical research and development is constantly advancing, and clinical trials play a crucial role in bringing new treatments and cures to patients. However, conducting a successful clinical trial is a complex and expensive undertaking with the average cost of bringing a drug to market being around $2.3B. Clinical trials require precise planning,…

  • Nonclinical development strategies to optimise your clinical development programme

    Nonclinical development strategies to optimise your clinical development programme

    Being first to market with an innovator drug remains the ultimate goal for all, and most organisations are constantly reviewing timelines in order to achieve efficiencies through trial design, conduct and the reduction of downtime between phases of drug development. But clinical trials and drug development is an expensive and slow process, representing approximately 60%…

  • Patient recruitment strategies for rare disease trials

    Patient recruitment strategies for rare disease trials

    One of the key challenges facing researchers working on treatments for rare diseases is recruitment for clinical trials. Because these diseases are relatively uncommon, it can be difficult to find enough patients to participate in studies and help advance treatment options. Additionally, there is often a lack of awareness for the condition, making it difficult…

  • The 4 Types of clinical trial monitoring

    The 4 Types of clinical trial monitoring

    In recent decades, clinical trials and their methodologies have evolved significantly. New technologies have led to improved research methods, techniques and strategies in clinical trial management and in site management and monitoring specifically. Additionally, new regulations and other external factors have resulted in changes to clinical trial approaches. For instance, social distancing restrictions during the…

  • Advantages and Disadvantages of Clinical Outsourcing

    Advantages and Disadvantages of Clinical Outsourcing

    Pharmaceutical companies all over the world outsource some or all elements of their clinical trials in order to better manage resources, improve efficiency and save their clinical development budget. However, with those budgets being squeezed ever tighter, whilst clinical outsourcing has many advantages, there are potential pitfalls if you choose the wrong Contract Research Organisation…

  • Considerations in rare disease study design

    Considerations in rare disease study design

    Designing a clinical trial is a complex and challenging process. There are several key factors that researchers have to consider, from patients, costs, practicalities, risk measures and much more. Designing clinical trials for rare disease studies can be especially challenging. Rare disease research comes with its own unique challenges, making it particularly important to overcome…

  • What is Research and Development in the Pharmaceutical Sector?

    What is Research and Development in the Pharmaceutical Sector?

    Pharmaceutical R&D is the process of developing drugs and pharmaceuticals so they are appropriate and safe for market use. The funding is usually from a mix of both private and public sources. Pharmaceutical R&D is important so that we can continue innovating and developing the most effective medicine and drugs to medicate people worldwide. In…